Circassia launches bookbuilding after long investor education
UK biotech firm Circassia began bookbuilding on its £210m IPO on Wednesday morning, after a longer than expected wait.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts